The DOI matches its Crossref record; 120 of the 121 references it cites were found in a registry or an index.
Iron and cancer: recent insights
Open accessAbstract
Iron is an essential dietary element. However, the ability of iron to cycle between oxidized and reduced forms also renders it capable of contributing to free radical formation, which can have deleterious effects, including promutagenic effects that can potentiate tumor formation. Dysregulation of iron metabolism can increase cancer risk and promote tumor growth. Cancer cells exhibit an enhanced dependence on iron relative to their normal counterparts, a phenomenon we have termed iron addiction. Work conducted in the past few years has revealed new cellular processes and mechanisms that deepen our understanding of the link between iron and cancer. Control of iron efflux through the combined action of ferroportin, an iron efflux pump, and its regulator hepcidin appears to play an important role in tumorigenesis. Ferroptosis is a form of iron‐dependent cell death involving the production of reactive oxygen species. Specific mechanisms involved in ferroptosis, including depletion of glutathione and inhibition of glutathione peroxidase 4, have been uncovered. Ferritinophagy is a newly identified mechanism for degradation of the iron storage protein ferritin. Perturbations of mechanisms that control transcripts encoding proteins that regulate iron have been observed in cancer cells, including differences in miRNA, methylation, and acetylation. These new insights may ultimately provide new therapeutic opportunities for treating cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“cancer cells have a high demand for easily accessible labile Fe2+ for their survival and growth.”
From Targeting cancer vulnerabilities with high-dose vitamin C (2019) · cites this paper as [23]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death
Dixon, S. J., Lemberg, K. M., Lamprecht, M. R., Skouta, R., Zaitsev, E. M., Gleason, C. E., Patel, D. N., Bauer, A. J., Cantley, A. M., Yang, W. S., et al. (2012) · Cell · doi:10.1016/j.cell.2012.03.042 · Cited by 18,691
Regulation of Ferroptotic Cancer Cell Death by GPX4
Yang, W. S., SriRamaratnam, R., Welsch, M. E., Shimada, K., Skouta, R., Viswanathan, V. S., Cheah, J. H., Clemons, P. A., Shamji, A. F., Clish, C. B., et al. (2014) · Cell · doi:10.1016/j.cell.2013.12.010 · Cited by 7,713
MicroRNAs: small RNAs with a big role in gene regulation
He, L., & Hannon, G. J. (2004) · Nature Reviews Genetics · doi:10.1038/nrg1379 · Cited by 7,118
Functions of DNA methylation: islands, start sites, gene bodies and beyond
Jones, P. A. (2012) · Nature Reviews Genetics · doi:10.1038/nrg3230 · Cited by 6,061
Inactivation of the ferroptosis regulator Gpx4 triggers acute renal failure in mice
Friedmann Angeli, J. P., Schneider, M., Proneth, B., Tyurina, Y. Y., Tyurin, V. A., Hammond, V. J., Herbach, N., Aichler, M., Walch, A., Eggenhofer, E., et al. (2014) · Nature Cell Biology · doi:10.1038/ncb3064 · Cited by 3,732
Ferroptosis as a p53-mediated activity during tumour suppression
Jiang, L., Kon, N., Li, T., Wang, S.-J., Su, T., Hibshoosh, H., Baer, R., & Gu, W. (2015) · Nature · doi:10.1038/nature14344 · Cited by 3,398
Blinded by the Light: The Growing Complexity of p53
Vousden, K. H., & Prives, C. (2009) · Cell · doi:10.1016/j.cell.2009.04.037 · Cited by 3,163
Wendel, A. (1981) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(81)77046-0 · Cited by 3,032
The role of iron and reactive oxygen species in cell death
Dixon, S. J., & Stockwell, B. R. (2014) · Nature Chemical Biology · doi:10.1038/nchembio.1416 · Cited by 2,381
Revisiting STAT3 signalling in cancer: new and unexpected biological functions
Yu, H., Lee, H., Herrmann, A., Buettner, R., & Jove, R. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3818 · Cited by 2,137
Dixon, S. J., Patel, D. N., Welsch, M., Skouta, R., Lee, E. D., Hayano, M., Thomas, A. G., Gleason, C. E., Tatonetti, N. P., Slusher, B. S., et al. (2014) · eLife · doi:10.7554/elife.02523 · Cited by 2,088
Quantitative proteomics identifies NCOA4 as the cargo receptor mediating ferritinophagy
Mancias, J. D., Wang, X., Gygi, S. P., Harper, J. W., & Kimmelman, A. C. (2014) · Nature · doi:10.1038/nature13148 · Cited by 2,084
Glutaminolysis and transferrin regulate ferroptosis
Gao, M., Monian, P., Quadri, N., Ramasamy, R., & Jiang, X. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.06.011 · Cited by 2,069
Sun, X., Ou, Z., Chen, R., Niu, X., Chen, D., Kang, R., & Tang, D. (2016) · Hepatology · doi:10.1002/hep.28251 · Cited by 2,012
WNT signalling pathways as therapeutic targets in cancer
Anastas, J. N., & Moon, R. T. (2012) · Nature reviews. Cancer · doi:10.1038/nrc3419 · Cited by 1,945
Brigelius-Flohé, R., & Maiorino, M. (2013) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2012.11.020 · Cited by 1,904
Yang, W. S., & Stockwell, B. R. (2008) · Chemistry & Biology · doi:10.1016/j.chembiol.2008.02.010 · Cited by 1,876
Mitochondrial metabolism and ROS generation are essential for Kras-mediated tumorigenicity
Weinberg, F., Hamanaka, R., Wheaton, W. W., Weinberg, S., Joseph, J., Lopez, M., Kalyanaraman, B., Mutlu, G. M., Budinger, G. R. S., & Chandel, N. S. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1003428107 · Cited by 1,742
RAS–RAF–MEK-dependent oxidative cell death involving voltage-dependent anion channels
Yagoda, N., von Rechenberg, M., Zaganjor, E., Bauer, A. J., Yang, W. S., Fridman, D. J., Wolpaw, A. J., Smukste, I., Peltier, J. M., Boniface, J. J., et al. (2007) · Nature · doi:10.1038/nature05859 · Cited by 1,631
Iron and cancer: more ore to be mined
Torti, S. V., & Torti, F. M. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3495 · Cited by 1,621
Self-citationDolma, S., Lessnick, S. L., Hahn, W. C., & Stockwell, B. R. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00050-3 · Cited by 1,446
McKie, A. T., Marciani, P., Rolfs, A., Brennan, K., Wehr, K., Barrow, D., Miret, S., Bomford, A., Peters, T. J., Farzaneh, F., et al. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)80425-6 · Cited by 1,422
Ganz, T., & Nemeth, E. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2012.01.014 · Cited by 1,282 · cited 1×
“Cells use this iron pool for (1) incorporation into prosthetic groups of iron-dependent enzymes and proteins, (2) incorporation into heme (after transport across the mitochondrial membrane) and iron–sulfur cluster biogenesis, and (3) storage in ferritin.”
BackgroundJansson, M., & Lund, A. H. (2012) · Molecular Oncology · doi:10.1016/j.molonc.2012.09.006 · Cited by 1,150
Ferrostatins Inhibit Oxidative Lipid Damage and Cell Death in Diverse Disease Models
Skouta, R., Dixon, S. J., Wang, J., Dunn, D. E., Orman, M., Shimada, K., Rosenberg, P. A., Lo, D. C., Weinberg, J. M., Linkermann, A., et al. (2014) · Journal of the American Chemical Society · doi:10.1021/ja411006a · Cited by 1,146
Synchronized renal tubular cell death involves ferroptosis
Linkermann, A., Skouta, R., Himmerkus, N., Mulay, S. R., Dewitz, C., De Zen, F., Prokai, A., Zuchtriegel, G., Krombach, F., Welz, P.-S., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1415518111 · Cited by 1,126
Regulation of cellular iron metabolism
Wang, J., & Pantopoulos, K. (2011) · Biochemical Journal · doi:10.1042/bj20101825 · Cited by 986 · cited 1×
“Cells use this iron pool for (1) incorporation into prosthetic groups of iron-dependent enzymes and proteins, (2) incorporation into heme (after transport across the mitochondrial membrane) and iron–sulfur cluster biogenesis, and (3) storage in ferritin.”
BackgroundIron homeostasis in host defence and inflammation
Ganz, T., & Nemeth, E. (2015) · Nature Reviews Immunology · doi:10.1038/nri3863 · Cited by 843
Dowdle, W. E., Nyfeler, B., Nagel, J., Elling, R. A., Liu, S., Triantafellow, E., Menon, S., Wang, Z., Honda, A., Pardee, G., et al. (2014) · Nature Cell Biology · doi:10.1038/ncb3053 · Cited by 759
Chan, S. Y., Zhang, Y.-Y., Hemann, C., Mahoney, C. E., Zweier, J. L., & Loscalzo, J. (2009) · Cell Metabolism · doi:10.1016/j.cmet.2009.08.015 · Cited by 702
T cell lipid peroxidation induces ferroptosis and prevents immunity to infection
Matsushita, M., Freigang, S., Schneider, C., Conrad, M., Bornkamm, G. W., & Kopf, M. (2015) · Journal of Experimental Medicine · doi:10.1084/jem.20140857 · Cited by 672
HSPB1 as a novel regulator of ferroptotic cancer cell death
Sun, X., Ou, Z., Xie, M., Kang, R., Fan, Y., Niu, X., Wang, H., Cao, L., & Tang, D. (2015) · Oncogene · doi:10.1038/onc.2015.32 · Cited by 666
Daniels‐Wells, T. R., Delgado, T., Rodríguez, J. A., Helguera, G. F., & Penichet, M. L. (2006) · Clinical Immunology · doi:10.1016/j.clim.2006.06.010 · Cited by 646
Drakesmith, H., Nemeth, E., & Ganz, T. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.09.006 · Cited by 638
A role of SMAD4 in iron metabolism through the positive regulation of hepcidin expression
Wang, R.-H., Li, C., Xu, X., Zheng, Y., Xiao, C., Zerfas, P., Cooperman, S., Eckhaus, M., Rouault, T., Mishra, L., et al. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.10.010 · Cited by 614
Heme oxygenase-1 accelerates erastin-induced ferroptotic cell death
Kwon, M.-Y., Park, E., Lee, S.-J., & Chung, S. W. (2015) · Oncotarget · doi:10.18632/oncotarget.5162 · Cited by 612
Mancias, J. D., Pontano Vaites, L., Nissim, S., Biancur, D. E., Kim, A. J., Wang, X., Liu, Y., Goessling, W., Kimmelman, A. C., & Harper, J. W. (2015) · eLife · doi:10.7554/elife.10308 · Cited by 552
Identification of artesunate as a specific activator of ferroptosis in pancreatic cancer cells
Eling, N., Reuter, L., Hazin, J., Hamacher-Brady, A., & Brady, N. R. (2015) · Oncoscience · doi:10.18632/oncoscience.160 · Cited by 524
The transferrin receptor part II: Targeted delivery of therapeutic agents into cancer cells
Daniels‐Wells, T. R., Delgado, T., Helguera, G. F., & Penichet, M. L. (2006) · Clinical Immunology · doi:10.1016/j.clim.2006.06.006 · Cited by 519
Iron Metabolism and the IRE/IRP Regulatory System: An Update
Pantopoulos, K. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1306.001 · Cited by 505
Mammalian iron metabolism and its control by iron regulatory proteins
Anderson, C. P., Shen, M., Eisenstein, R. S., & Leibold, E. A. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2012.05.010 · Cited by 493
Lund, A. H., & van Lohuizen, M. (2004) · Genes & Development · doi:10.1101/gad.1232504 · Cited by 489
Yan, Y., Xie, Y., Cao, L., Yang, L., Yang, M., Lotze, M. T., Zeh, H. J., Kang, R., & Tang, D. (2015) · Molecular & Cellular Oncology · doi:10.1080/23723556.2015.1054549 · Cited by 476
Hayano, M., Yang, W., Corn, C. K., Pagano, N. C., & Stockwell, B. R. (2015) · Cell Death and Differentiation · doi:10.1038/cdd.2015.93 · Cited by 468
Hepcidin and disorders of iron metabolism
Ganz, T., & Nemeth, E. (2011) · Annual Review of Medicine · doi:10.1146/annurev-med-050109-142444 · Cited by 466
Ferroportin and Iron Regulation in Breast Cancer Progression and Prognosis
Pinnix, Z. K., Miller, L. D., Wang, W., D’Agostino, R., Kute, T., Willingham, M. C., Hatcher, H., Tesfay, L., Sui, G., Di, X., et al. (2010) · Science Translational Medicine · doi:10.1126/scitranslmed.3001127 · Cited by 448
Self-citationMeister, A. (1995) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/0076-6879(95)51106-7 · Cited by 429
Mechanistic and regulatory aspects of intestinal iron absorption
Gulec, S., Anderson, G. J., & Collins, J. F. (2014) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00348.2013 · Cited by 406
Sorafenib induces ferroptosis in human cancer cell lines originating from different solid tumors.
Lachaier, E., Louandre, C., Godin, C., Saidak, Z., Baert, M., Diouf, M., Chauffert, B., & Galmiche, A. (2014) · PubMed · Cited by 396
Artemisinin derivatives induce iron-dependent cell death (ferroptosis) in tumor cells
Ooko, E., Saeed, M. E. M., Kadioglu, O., Sarvi, S., Colak, M., Elmasaoudi, K., Janah, R., Greten, H. J., & Efferth, T. (2015) · Phytomedicine · doi:10.1016/j.phymed.2015.08.002 · Cited by 387
Múñoz, M., Villar, I., & García‐Erce, J. A. (2009) · World Journal of Gastroenterology · doi:10.3748/wjg.15.4617 · Cited by 381
Beyond TGFβ: roles of other TGFβ superfamily members in cancer
Wakefield, L. M., & Hill, C. S. (2013) · Nature reviews. Cancer · doi:10.1038/nrc3500 · Cited by 379
Louandre, C., Marcq, I., Bouhlal, H., Lachaier, E., Godin, C., Saidak, Z., François, C., Chatelain, D., Debuysscher, V., Barbare, J.-C., et al. (2015) · Cancer Letters · doi:10.1016/j.canlet.2014.11.014 · Cited by 374
Iron and Cancer Risk—A Systematic Review and Meta-analysis of the Epidemiological Evidence
Fonseca‐Nunes, A., Jakszyn, P. G., & Agudo, A. (2013) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-13-0733 · Cited by 357 · cited 1×
“Cells use this iron pool for (1) incorporation into prosthetic groups of iron-dependent enzymes and proteins, (2) incorporation into heme (after transport across the mitochondrial membrane) and iron–sulfur cluster biogenesis, and (3) storage in ferritin.”
BackgroundPreferential Iron Trafficking Characterizes Glioblastoma Stem-like Cells
Schonberg, D. L., Miller, T. E., Wu, Q., Flavahan, W. A., Das, N. K., Hale, J. S., Hubert, C. G., Mack, S. C., Jarrar, A., Karl, R. T., et al. (2015) · Cancer Cell · doi:10.1016/j.ccell.2015.09.002 · Cited by 356
Mechanisms and biological relevance of lipid peroxidation initiation
Dix, T. A., & Aikens, J. (1993) · Chemical Research in Toxicology · doi:10.1021/tx00031a001 · Cited by 338
The physiological functions of iron regulatory proteins in iron homeostasis - an update
Zhang, D., Ghosh, M. C., & Rouault, T. A. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00124 · Cited by 310
An overview of molecular basis of iron metabolism regulation and the associated pathologies
Silva, B., & Faustino, P. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2015.03.011 · Cited by 300
Ruddell, R. G., Hoang‐Le, D., Barwood, J. M., Rutherford, P. S., Piva, T. J., Watters, D. J., Santambrogio, P., Arosio, P., & Ramm, G. A. (2009) · Hepatology · doi:10.1002/hep.22716 · Cited by 298
Cellular and metabolic functions for autophagy in cancer cells
Kenific, C. M., & Debnath, J. (2014) · Trends in Cell Biology · doi:10.1016/j.tcb.2014.09.001 · Cited by 270
Taylor, M., Qu, A., Anderson, E. R., Matsubara, T., Martin, A., Gonzalez, F. J., & Shah, Y. M. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.03.007 · Cited by 265
Aminoferrocene-Based Prodrugs Activated by Reactive Oxygen Species
Hagen, H., Marzenell, P., Jentzsch, E., Wenz, F. K., Veldwijk, M. R., & Mokhir, A. A. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm2014937 · Cited by 262
Macciò, A., Madeddu, C., Gramignano, G., Mulas, C., Tanca, L., Cherchi, M. C., Floris, C., Omoto, I., Barracca, A., & Ganz, T. (2014) · Haematologica · doi:10.3324/haematol.2014.112813 · Cited by 261
Activation of Transferrin Receptor 1 by c-Myc Enhances Cellular Proliferation and Tumorigenesis
O’Donnell, K. A., Yu, D., Zeller, K. I., Kim, J., Racke, F. K., Thomas‐Tikhonenko, A., & Dang, C. V. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.6.2373-2386.2006 · Cited by 251
The liver-specific microRNA miR-122 controls systemic iron homeostasis in mice
Castoldi, M., Spasić, M. V., Altamura, S., Elmén, J., Lindow, M., Kiss, J., Stolte, J., Sparla, R., D’Alessandro, L. A., Klingmüller, U., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci44883 · Cited by 248
Development of small-molecule probes that selectively kill cells induced to express mutant RAS
Weïwer, M., Bittker, J. A., Lewis, T. A., Shimada, K., Yang, W. S., MacPherson, L., Dandapani, S., Palmer, M., Stockwell, B. R., Schreiber, S. L., et al. (2012) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2011.09.047 · Cited by 237
Harada, N., Kanayama, M., Maruyama, A., Yoshida, A., Tazumi, K., Hosoya, T., Mimura, J., Toki, T., Maher, J. M., Yamamoto, M. P., et al. (2011) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2011.02.001 · Cited by 236
Habashy, H. O., Powe, D. G., Staka, C. M., Rakha, E. A., Ball, G., Green, A. R., Aleskandarany, M., Paish, E. C., Douglas Macmillan, R., Nicholson, R. I., et al. (2010) · Breast Cancer Research and Treatment · doi:10.1007/s10549-009-0345-x · Cited by 236
Dynamic roles of p53-mediated metabolic activities in ROS-induced stress responses
Jiang, L., Hickman, J. H., Wang, S.-J., & Gu, W. J. (2015) · Cell Cycle · doi:10.1080/15384101.2015.1068479 · Cited by 235
Selective killing of K-ras mutant cancer cells by small molecule inducers of oxidative stress
Shaw, A. T., Winslow, M. M., Magendantz, M., Ouyang, C., Dowdle, J. A., Subramanian, A., Lewis, T. A., Maglathin, R. L., Tolliday, N. J., & Jacks, T. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1105941108 · Cited by 232
Hepcidin: regulation of the master iron regulator
Rishi, G., Wallace, D. F., & Subramaniam, V. N. (2015) · Bioscience Reports · doi:10.1042/bsr20150014 · Cited by 223
Role of ferritin alterations in human breast cancer cells
Shpyleva, S., Tryndyak, V., Kovalchuk, O., Starlard‐Davenport, A., Chekhun, V. F., Beland, F. A., & Pogribny, I. P. (2010) · Breast Cancer Research and Treatment · doi:10.1007/s10549-010-0849-4 · Cited by 205
Hou, W., Tian, Q., Zheng, J., & Bonkovsky, H. L. (2009) · Hepatology · doi:10.1002/hep.23401 · Cited by 200
Hepcidin regulation in prostate and its disruption in prostate cancer
Tesfay, L., Clausen, K. A., Kim, J. W., Hegde, P., Wang, X., Miller, L. D., Deng, Z., Blanchette, N., Arvedson, T., Miranti, C. K., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-2465 · Cited by 186
Self-citationThe role of the iron responsive element in the control of ferroportin1/IREG1/MTP1 gene expression
Lymboussaki, A., Pignatti, E., Montosi, G., Garuti, C., Haile, D. J., & Pietrangelo, A. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(03)00408-2 · Cited by 182
Torti, S. V., & Torti, F. M. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-3614 · Cited by 162
Self-citationSignaling Role of Intracellular Iron in NF-κB Activation
Xiong, S., She, H., Takeuchi, H., Han, B., Engelhardt, J. F., Barton, C. H., Zandi, E., Giulivi, C., & Tsukamoto, H. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210905200 · Cited by 161
Regulation of glutathione levels in mouse spleen lymphocytes by transport of cysteine
Ishii, T., Sugita, Y., & Bannai, S. (1987) · Journal of Cellular Physiology · doi:10.1002/jcp.1041330217 · Cited by 158
Alkhateeb, A. A., Han, B., & Connor, J. R. (2013) · Breast Cancer Research and Treatment · doi:10.1007/s10549-012-2405-x · Cited by 155
Iron homeostasis and tumorigenesis: molecular mechanisms and therapeutic opportunities
Zhang, C., & Zhang, F. (2014) · Protein & Cell · doi:10.1007/s13238-014-0119-z · Cited by 149
Delaby, C., Pilard, N., Puy, H., & Canonne-Hergaux, F. (2008) · Biochemical Journal · doi:10.1042/bj20071474 · Cited by 144
A role for iron in Wnt signalling
Brookes, M. J., Boult, J., Roberts, K., Cooper, B. T., Hotchin, N. A., Matthews, G., Iqbal, T., & Tselepis, C. (2008) · Oncogene · doi:10.1038/sj.onc.1210711 · Cited by 139
miR-320 targets transferrin receptor 1 (CD71) and inhibits cell proliferation
Schaar, D. G., Medina, D. J., Moore, D. F., STRAIR, R. K., & Ting, Y. (2009) · Experimental Hematology · doi:10.1016/j.exphem.2008.10.002 · Cited by 136
Disordered hepcidin–ferroportin signaling promotes breast cancer growth
Zhang, S., Chen, Y., Guo, W., Yuan, L., Zhang, D., Xu, Y., Nemeth, E., Ganz, T., & Liu, S. (2014) · Cellular Signalling · doi:10.1016/j.cellsig.2014.07.029 · Cited by 132
Iron-Responsive miR-485-3p Regulates Cellular Iron Homeostasis by Targeting Ferroportin
Sangokoya, C., Doss, J. F., & Chi, J. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003408 · Cited by 129
HDAC Inhibitors as Novel Anti-Cancer Therapeutics
Souza, C. D., & Chatterji, B. P. (2015) · Recent Patents on Anti-Cancer Drug Discovery · doi:10.2174/1574892810666150317144511 · Cited by 123
Ferritin, a Hodgkin's Disease Associated Antigen
Eshhar, Z., Order, S. E., & Katz, D. H. (1974) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.71.10.3956 · Cited by 111
Marzenell, P., Hagen, H., Sellner, L., Zenz, T., Grinyte, R., Pavlov, V. V., Daum, S., & Mokhir, A. A. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm400754c · Cited by 108
Increased hepcidin expression in colorectal carcinogenesis
Ward, D. G., Roberts, K., Brookes, M., Joy, H., Martin, A., Ismail, T., Spychal, R., Iqbal, T. H., & Tselepis, C. (2008) · World Journal of Gastroenterology · doi:10.3748/wjg.14.1339 · Cited by 105
Hou, W., Tian, Q., Steuerwald, N., Schrum, L. W., & Bonkovsky, H. L. (2012) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2012.06.001 · Cited by 103
Marcus, D. M., & Zinberg, N. (1974) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(74)90209-4 · Cited by 96
Cancer cells with irons in the fire
Bystrom, L. M., & Rivella, S. (2014) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2014.04.035 · Cited by 90
Andolfo, I., Falco, L. D., Asci, R., Russo, R., Colucci, S., Gorrese, M., Zollo, M., & Iolascon, A. (2010) · Haematologica · doi:10.3324/haematol.2009.020685 · Cited by 90
Serum and tumour ferritins in primary liver cancer.
Kew, M. C., Torrance, J. D., Derman, D. P., Simon, M., MACNAB, G. M., Charlton, R. W., & Bothwell, T. H. (1978) · Gut · doi:10.1136/gut.19.4.294 · Cited by 88
Micromanaging Iron Homeostasis
Yoshioka, Y., Kosaka, N., Ochiya, T., & Kato, T. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.356717 · Cited by 86
An important role of the hepcidin–ferroportin signaling in affecting tumor growth and metastasis
Guo, W., Zhang, S., Chen, Y., Zhang, D., Yuan, L., Cong, H., & Liu, S. (2015) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmv063 · Cited by 84
Jeong, D. E., Song, H. J., Lim, S., Lee, S. J., Lim, J. E., Nam, D., Joo, K. M., Jeong, B. C., Jeon, S. S., Choi, H. Y., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.5422 · Cited by 81
Iron: An emerging factor in colorectal carcinogenesis
Chua, A. C. G. (2010) · World Journal of Gastroenterology · doi:10.3748/wjg.v16.i6.663 · Cited by 77
Distribution of ferritin, transferrin and lactoferrin in breast carcinoma tissue
Rossiello, R., Carriero, M. V., & Giordano, G. G. (1984) · Journal of Clinical Pathology · doi:10.1136/jcp.37.1.51 · Cited by 72
Kamai, T., Tomosugi, N., Abe, H., Arai, K., & Yoshida, K. (2009) · BMC Cancer · doi:10.1186/1471-2407-9-270 · Cited by 65
miR-214 Regulates Lactoferrin Expression and Pro-Apoptotic Function in Mammary Epithelial Cells ,
Liao, Y., Du, X., & Lönnerdal, B. L. (2010) · Journal of Nutrition · doi:10.3945/jn.110.124289 · Cited by 62
Iron homeostasis and anemia markers in early breast cancer
Lamy, P., Durigova, A., & Jacot, W. (2014) · Clinica Chimica Acta · doi:10.1016/j.cca.2014.04.011 · Cited by 60
Tisi, M. C., Bozzoli, V., Giachelia, M., Massini, G., Ricerca, B. M., Maiolo, E., D’Alo’, F., Larocca, L. M., Piciocchi, A., Tjalsma, H., et al. (2014) · Leukemia & Lymphoma · doi:10.3109/10428194.2013.802314 · Cited by 59
Modulation of hepcidin to treat iron deregulation: potential clinical applications
Blanchette, N. L., Manz, D. H., Torti, F. M., & Torti, S. V. (2015) · Expert Review of Hematology · doi:10.1586/17474086.2016.1124757 · Cited by 59
Self-citationDisordered signaling governing ferroportin transcription favors breast cancer growth
Chen, Y., Zhang, S., Wang, X., Guo, W., Wang, L., Zhang, D., Yuan, L., Zhang, Z., Xu, Y., & Liu, S. (2014) · Cellular Signalling · doi:10.1016/j.cellsig.2014.11.002 · Cited by 54
Tissue ferritin concentration and prognosis in carcinoma of the breast
Weinstein, R. E., Bond, B. H., Silberberg, B. K., Vaughn, C. B., Subbaiah, P., & Pieper, D. R. (1989) · Breast Cancer Research and Treatment · doi:10.1007/bf01806307 · Cited by 50
Roles of the hepcidin–ferroportin axis and iron in cancer
Wu, X., Su, D., Wang, L., & Yu, F. (2013) · European Journal of Cancer Prevention · doi:10.1097/cej.0b013e3283627f14 · Cited by 42
Liao, Y., & Lönnerdal, B. (2009) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2009.07.019 · Cited by 40
HEPCIDIN, ANAEMIA, AND PROSTATE CANCER
Tanno, T., Rabel, A., Alleyne, M., Lee, Y. T., Dahut, W. L., Gulley, J. L., & Miller, J. L. (2011) · British Journal of Urology · doi:10.1111/j.1464-410x.2011.10108.x · Cited by 37
Alterations in expression profile of iron-related genes in colorectal cancer
Hamara, K., Bielecka-Kowalska, A., Przybyłowska-Sygut, K., Sygut, A., Dziki, A. J., & Szemraj, J. (2013) · Molecular Biology Reports · doi:10.1007/s11033-013-2659-3 · Cited by 35
Hepcidin and GDF15 in anemia of multiple myeloma
Mei, S.-C., Wang, H., Fu, R., Qü, W., Xing, L., Wang, G., Song, J., Liu, H., Li, L., Wang, X., et al. (2014) · International Journal of Hematology · doi:10.1007/s12185-014-1626-7 · Cited by 31
MicroRNA‐210 Decreases heme Levels by Targeting Ferrochelatase in Cardiomyocytes
Qiao, A., Khechaduri, A., Mutharasan, R. K., Wu, R., Nagpal, V., & Ardehali, H. (2013) · Journal of the American Heart Association · doi:10.1161/jaha.113.000121 · Cited by 31
Endofin, a novel BMP-SMAD regulator of the iron-regulatory hormone, hepcidin
Goh, J. B., Wallace, D. F., Hong, W., & Subramaniam, V. N. (2015) · Scientific Reports · doi:10.1038/srep13986 · Cited by 29
Krishan, S., Jansson, P. J., Gutierrez, E., Lane, D. J. R., Richardson, D. R., & Sahni, S. (2015) · PubMed Central · doi:10.18999/nagjms.77.1-2.1 · Cited by 28
Ikenberg, H., Matthay, K., Schmitt, B., Bauknecht, T., Kiechle‐Schwarz, M., Göppinger, A., & Pfleiderer, A. (1995) · Cancer · doi:10.1002/1097-0142(19950701)76:1 · Cited by 28
El-Monem, E. A., Tharwa, E.-S., Ma, F., Fawzy, A., Sf, E. S., & Suliman, S. (2009) · PubMed · Cited by 27
Ferritin H induction by histone deacetylase inhibitors
Wang, W., Di, X., Torti, S. V., & Torti, F. M. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.04.008 · Cited by 23
Self-citationFerroptosis: A Novel Form of Cancer Cell Death Induced by the Small Molecule Erastin
Lemberg, K. M. (2011) · doi:10.7916/d8n87hz3 · Cited by 2
Abstract 920: Mechanism of the transferrin receptor 1 dysregulation in hepatocarcinogenesis
Kindrat, I., Tryndyak, V., de Conti, A., Shpyleva, S., Еrstenyuk, H. M., Beland, F. A., & Pogribny, I. P. (2015) · Cancer Research · doi:10.1158/1538-7445.am2015-920 · Cited by 1
Weinstein (1982) · doi:10.1002/1097-0142(19821201)50:11
Flagged first, then by citations
1 of the 121 references couldn’t be matched to a known paper.
Research works printed but not linked: 1
- 10.1371/journal.pgen.1003408 · DOI
Cited by
Sorted by citations
Ferroptosis: mechanisms, biology and role in disease
Jiang, X., Stockwell, B. R., & Conrad, M. (2021) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-020-00324-8 · Cited by 7,973
Hayes, J. D., Dinkova-Kostova, A. T., & Tew, K. D. (2020) · Cancer Cell · doi:10.1016/j.ccell.2020.06.001 · Cited by 2,654
Ferroptosis in cancer therapy: a novel approach to reversing drug resistance
Zhang, C., Liu, X., Jin, S., Chen, Y., & Guo, R. (2022) · Molecular Cancer · doi:10.1186/s12943-022-01530-y · Cited by 1,382
“Cancer cells have been shown to have increased iron requirements for survival in comparison to normal cells [24].”
BackgroundLipid Peroxidation and Iron Metabolism: Two Corner Stones in the Homeostasis Control of Ferroptosis
Rochette, L., Dogon, G., Rigal, E., Zeller, M., Cottin, Y., & Vergely, C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms24010449 · Cited by 966
“Several modulators of ferroptosis have been identified through the study of ferroptotic mechanisms [52].”
BackgroundFerroptosis in cancer: from molecular mechanisms to therapeutic strategies
Zhou, Q., Meng, Y., Li, D., Yao, L., Le, J., Liu, Y., Sun, Y., Zeng, F., Chen, X., & Deng, G. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01769-5 · Cited by 1,056
“11,368,369 Intriguingly, mesenchymal and dedifferentiated cancer cells, which are usually resistant to apoptosis and traditional therapies, are exquisitely vulnerable to ferropto-sis.”
Background
Metadata
- Authors
- Manz, D. H., Blanchette, N. L., Paul, B. T., Torti, F. M., & Torti, S. V.
- Affiliations
- Department of Molecular Biology and Biophysics
- UConn Health (US)
- Corresponding author
- Torti, Suzy V.
- Venue
- Annals of the New York Academy of Sciences
- Publisher
- Wiley
- Published
- 2016-02-18
- Volume
- 1368
- Issue
- 1
- Pages
- 149-161
- ISSN
- 0077-8923 (ISSN-L)
- 1749-6632
- PMC
- PMC4870095
- OpenAlex
- W2275201610
- Cited by
- 507
- References
- 121
- Citations by year
- 2026: 24 · 2025: 49 · 2024: 69 · 2023: 78 · 2022: 66 · 2021: 77 · 2020: 46 · 2019: 43 · 2018: 31 · 2017: 14 · 2016: 10
- FWCI
- 4.64
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Annals of the New York Academy of Sciences (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- S.V.T (CA188025)
- F.M.T (CA171101)
- D.H.M. (DE021989)
- U.S. National Institutes of Health
- Topics
- Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Ferroptosis and cancer prognosis
- Health Sciences › Nursing › Nutrition and Dietetics › Trace Elements in Health
- Keywords
- iron metabolism, cancer, ferroptosis, ferroportin, hepcidin, iron efflux, reactive oxygen species, glutathione depletion, GPX4, ferritinophagy, ferritin degradation, tumor microenvironment, epigenetic regulation, microRNA, DNA methylation, histone acetylation, cancer therapy
- MeSH terms
- Ferroportin, Animals, Humans, Iron, Neoplasms, Reactive Oxygen Species, Iron Overload, Cation Transport Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review